FDA's Pazdur Advocates Platform Trials For Cancer Drug Development

US FDA is encouraging common mechanisms of drug testing to enable pharma industry collaboration and avoid redundancy; Pazdur notes that there are many similar PD-1 drugs.

Cancer treatment - diagnosis written on a white piece of paper. Syringe and vaccine with drugs. - Image
US FDA official calls for industry collaboration in cancer drug development

More from Clinical Trials

More from R&D